Eric Sullivan - 27 Jun 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role
Chief Financial Officer
Signature
/s/ Eric Sullivan
Issuer symbol
N/A
Transactions as of
27 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 17:18:30 UTC
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 27 Jun 2022 Common Stock 250,000 $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on June 27, 2023, with the remainder vesting in thirty-six 36 equal monthly installments thereafter.